June 19, 2009 (Copenhagen, Denmark) — "Real-life" studies in patients with lupus nephritis show that intravenous (IV) cyclophosphamide is superior to oral cyclophosphamide as induction therapy and ...

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23 PURPOSE: To determine the ...

The benefits of moderate dose intravenous cyclophosphamide (CYC) immunosuppressive therapy, a preferred treatment for severe lupus, may outweigh concerns of risk of ovarian dysfunction in young women ...

Iv cytoxan orders no rx needed online Cyclophosphamide CYC has long been considered a gold standard in inducing renal remission and preventing renal flares for patients with systemic lupus ...

MMF induction is a viable alternative to cyclophosphamide for treating mixed proliferative lupus nephritis in children. Oral mycophenolate mofetil (MMF) is as effective as intravenous cyclophosphamide ...

All patients had a complete history and physical examination including documentation of weight, Karnofsky performance status, presence of measurable or evaluable disease, a complete blood count with ...

There is currently no consensus as to whether cyclophosphamide is better than azathioprine, in combination with corticosteroids, for the treatment of proliferative lupus nephritis—although ...

In a phase III trial, oral tacrolimus (Prograf) proved non-inferior to intravenous cyclophosphamide for treating lupus nephritis, researchers said. Among 158 patients randomized to tacrolimus, 83.0% ...

Please provide your email address to receive an email when new articles are posted on . New Pan American League of Associations for Rheumatology recommendations include remission maintenance ...

In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide. Tacrolimus, a calcineurin inhibitor, appears to be an effective alternative to ...